UPDATE 1-UK's CMA says Illumina-Pacific Biosciences deal could hurt competition
June 18, 2019 at 07:30 AM EDT
Britain's competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of California Inc may be a threat to competition in the country.